Alnylam Pharmaceuticals, Inc.

DUL.F·Frankfurt·Healthcare
Compare
201.300.00 (0.00%)today
As of Oct 21, 7:55 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close201.30
Open205.20
Day range200.60205.20
52-week range173.50414.60
Off day high−1.90%
Off 52-week high−51.45%
Volume11.00
Avg. volume (3M)35.00
Market cap26.94B
EPS (TTM)5.16
Forward P/E-53.54
P/E ratio (TTM)39.01
Dividend yield—
Beta (5Y)0.27
Shares outstanding133.81M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin16.13%

Against its peers

Compare in full ›
DUL.F IONS ARWR BBIO ROIV 6855.HK
Market cap 26.94B 7.36B 8.31B 13.24B 26.58B 10.65B
P/E (TTM) 39.0 — — — — —
Forward P/E -53.5 -38.6 -11.8 -301.6 -21.4 -73.5
Price/book 22.3 16.7 17.8 -5.3 6.3 16.3
Dividend yield — — — — — —
1-year change −49.01% −38.08% +57.54% +25.89% +103.09% −52.27%
Today 0.00% −2.49% −0.14% +0.28% +5.38% −8.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All DUL.F news ›

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.